Professional Overview

Martin Perez Segado is a seasoned financial executive currently serving as the Chief Financial Officer (CFO) at Laboratorios Normon, located in Madrid, Spain. His expertise spans financial management, logistics, distribution, strategy, and business development, with a strong focus on the pharmaceutical and healthcare industries.

Experience Summary

Current Role

As CFO at Laboratorios Normon, Martin oversees all financial aspects of the company, including budgeting, forecasting, and financial reporting. Additionally, he serves as an Advisory Specialist at Guidepoint and an Advisory Council Member at GERSON LEHRMAN GROUPO LIMITED. His current responsibilities encompass providing strategic financial guidance, driving business growth, and ensuring regulatory compliance.

Career Progression

Martin's career trajectory is marked by progressive leadership roles. Notable previous positions include Logistics and Distribution Director, Strategy and Business Development Director at Grupo Prim, General Manager at Grupo Cofares, and CFO at Grupo Mémora and Alhambra-Eidos. These roles have equipped him with a deep understanding of operational management, strategic planning, and financial leadership.

Areas of Expertise

Martin's expertise includes financial planning, risk management, logistics optimization, and strategic business development. He possesses technical competencies in financial analysis, budgeting, and forecasting, combined with strong leadership and management capabilities.

Professional Impact

Throughout his career, Martin has driven significant business growth, improved operational efficiency, and ensured regulatory compliance in his respective roles. While specific metrics are not available, his consistent progression to leadership roles underscores his value as a strategic financial executive.

Conclusion

Martin Perez Segado's professional trajectory is defined by his commitment to financial excellence, strategic vision, and leadership. Currently, as CFO at Laboratorios Normon, he continues to drive financial growth and stability. His value proposition lies in his unique blend of financial, operational, and strategic expertise, making him a key asset in the pharmaceutical and healthcare industries.